KNOSIS Physical Therapy
- Biofeedback Therapy
- Shockwave Therapy
- Arthritis Treatment
- Red Light Therapy
- TMJ Treatment
New York, NY
Biofeedback Therapy clinics in New York
New York is the densest healthcare market in the country, with academic powerhouses alongside boutique integrative clinics in Manhattan and Brooklyn. Biofeedback is a non-invasive training modality that uses sensors to give patients real-time feedback on physiological processes such as heart rate variability, muscle tension, skin conductance, or brain activity. It is FDA-cleared for relaxation and is used clinically for anxiety, migraine, chronic pain, pelvic floor dysfunction, attention issues, and stress-related conditions.
Most legitimate practitioners hold certification through the Biofeedback Certification International Alliance, or BCIA, which sets training standards across general biofeedback, neurofeedback, and pelvic muscle dysfunction tracks. Sessions are typically weekly, skills-based, and paired with at-home practice. Evidence is Strong for tension and migraine headache, Emerging for anxiety and ADHD, and varies by condition and protocol.
The 7 practices listed below include general biofeedback, neurofeedback, and integrative clinics. Confirm certification and clinical match before booking.
New York Headache Center
- Biofeedback Therapy
- IV Therapy
- Transcranial Magnetic Stimulation (TMS)
- Migraine Treatment
Regulatory context
A note on New York's biofeedback therapy rules.
Repetitive transcranial magnetic stimulation (rTMS) is regulated as a Class II prescription device. The first 510(k) clearance went to NeuroStar in 2008 for treatment-resistant major depressive disorder. Subsequent clearances expanded the on-label scope to obsessive-compulsive disorder (BrainsWay deep TMS, 2018), smoking cessation (BrainsWay, 2020), anxious depression as an adjunct indication (2021), and migraine via single-pulse TMS devices such as eNeura SpringTMS and SAVI Dual. Biofeedback instruments are cleared under 21 CFR 882.1425 as Class II devices for relaxation training and stress reduction. EEG-based neurofeedback systems hold 510(k) clearances in the same category. Cranial electrotherapy stimulation, tDCS wellness devices, and many vagus nerve stimulation accessories sold direct to consumers are not cleared as medical devices, and clinical claims beyond cleared indications are off-label.
-
New York Education Law Article 131 (Medicine)
Defines the practice of medicine and supervision framework for delegated procedures including TMS technician work. -
New York Education Law Article 153 (Psychology)
Governs licensed psychologists who deliver biofeedback and neurofeedback within scope. -
New York General Business Law Sections 349 and 350
Supports attorney general action against deceptive medical device advertising.
The New York State Office of Professional Medical Conduct investigates TMS clinics for supervision lapses, corporate practice violations, and off-label marketing. New York enforces a strong corporate practice of medicine doctrine and requires Professional Service Corporation or similar structures for clinical ownership. The New York attorney general pursues General Business Law Sections 349 and 350 actions against deceptive medical device advertising, including neurofeedback cure claims. Commercial insurers and New York Medicaid typically require documented treatment-resistant depression before covering TMS for major depressive disorder.